The risks of developing prostate cancer by the age of 75 years were reportedly 21% and 27% for BRCA1 and BRCA2 GPV carriers, respectively, and the risks of developing pancreatic cancer by 75 years were reportedly 1–3% and 3–5% for BRCA1 and BRCA2 GPV carriers, respectively [55,56,57]. The gene discussed is BRCA2; the disease is prostate carcinoma.